Skip to main content
OpenTrials
Completed

NCT Number: NCT05926089

Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia

This study is a cross-sectional study, was conducted at Chest department of Kasr Al-ainy Hospital, Cairo university during the period between October 2020 and April 2021.

The aim of the work was to evaluate levels of acute phase reactants(APR) in Non-COVID-19 bacterial pneumonia, and to correlate between levels of APR and the disease severity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pneumonia Acute-Phase Reaction Infections Inflammation Lung Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases Respiratory Tract Infections

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kasr alainy school of medicine

Cairo, 11562, Egypt

About this study

51 patients were included in our study, diagnosed as Non-COVID pneumonia

Inclusion criteria

  • PCR(polymerase chain reaction) negative for COVID.
  • All patients of both sexes with pneumonia .

Exclusion criteria

  • Non pulmonary infections.
  • Post surgery patients.
  • Renal patients.
  • hepatic patients.
  • Cardiac patients.
  • Recent pulmonary embolism.

Methodology in details:

All patients were subjected to:

  • Full history with emphasis on:
  • Epidemiological features (age, gender).
  • Risk factors (smoking, DM).
  • Clinical presentation (cough, Fever and duration of illness).
  • Clinical examination (local chest examination).
  • Laboratory investigations: venous blood samples were taken to measure APR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COVID-19 negative bacterial pneumonia

Exclusion criteria

  • COVID-19 positive
  • other non-pulmonary infections

Treatment and study plan

Blood sampling

Diagnostic Test

blood sampling to measure APR

Primary outcomes

  1. measurement of APR levels in non-Covid-19 pneumonia

    Time frame: 6 months

    assessment of the level of APR and its relation to disease severity

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Acute Phase Reactant in Non-COVID-19 Community Acquired Pneumonia

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jul 3, 2023
Registry last updated
Jul 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.